Table 2.
Summary of All Available Crystal Structures of GPCRs (Based on [61])
| GPCR | Engineered | Type of ligand | Ligand name | PDB ID (Resolution Å) [Reference] |
|---|---|---|---|---|
| A2AR (human) | IC3 fusion | Agonist | UK-432097 | 3QAK (2.71) [101] |
| Inverse agonist | ZM241385 | 3EML (2.6) [98] | ||
| Point mutations | Agonist | Adenosine | 2YDO (3.0) [105] | |
| Agonist | NECA | 2YDV (2.6) [105] | ||
| Antagonist | Caffeine | 3RFM (3.60) [106] | ||
| Antagonist | XAC | 3REY (3.31) [106] | ||
| Inverse agonist | ZM241385 | 3PWH (3.30) [106] | ||
| β1AR (turkey) | Point mutations | Agonist | Carmoterol | 2Y02 (2.6) [104] |
| Agonist | Isoprenaline | 2Y03 (2.85] [104] | ||
| Antagonist | Cyanopindolol | 2VT4 (2.7) [74], 2YCX (3.25) [159], 2YCY (3.15) [159], 2YCZ (3.65) [159] | ||
| Inverse agonist | Carazolol | 2YCW (3.0) [159] | ||
| Partial agonist | Dobutamine | 2Y00 (2.5) [104], 2Y01 (2.6) [104] | ||
| Partial agonist | Salbutamol | 2Y04 (3.05) [104] | ||
| β2AR (human) | IC3 fusion | Agonist | BI-167107, nanobody | 3P0G (3.5) [96] |
| Agonist | FAUC50 | 3PDS (3.5) [96] | ||
| Antagonist | Alprenolol | 3NYA (3.16) [97] | ||
| Inverse agonist | Carazolol | 2RH1 (2.4) [18] | ||
| Inverse agonist | Compound #1 | 3NY9 (2.84) [97] | ||
| Inverse agonist | ICI118551 | 3NY8 (2.84 [97] | ||
| Inverse agonist | Timolol | 3DS4 (2.8) [59] | ||
| Inverse agonist | FAB, not resolved | 2R4R (3,4) [96], 2R4S (3.4) [96] | ||
| Inverse agonist | FAB, not resolved | 3KJ6 (3.4) [135] | ||
| N-terminal fusion | Agonist | BI-167107, Gαβγ, nanobody | 3SN6 (3.2) [15] | |
| CXCR4 (human) | IC3 fusion | Antagonist | CVX15 peptide | 3OE0 (2.9) [33] |
| Antagonist | Molecule 1t | 3ODU (2.5) [33], 3OE6 (3.2) [33], 3OE8 (3.1) [33], 3OE9 (3.1)[33] | ||
| D3R (human) | IC3 fusion | Antagonist | Eticlopride | 3PBL (2.89) [99] |
| H1R (human) | IC3 fusion | Inverse agonist | Doxepin | 3RZE (3.1) 36 [100] |
| Opsin | 3CAP (2.9) [89] | |||
| Gα peptide | 3DQB (3.2) [91] | |||
| Rhodopsin (bovine) | Agonist | All-trans-retinal | 2G87 (2.6) [139] | |
| Inverse agonist | 11-cis-retinal | 1F88 (2.8) [17], 1U19 (2.2) [83], 1GZM (2.65) [83], L9H (2.6) [83], 1HZX (2.8) [83], 2I37 (4.0) [83], 3OAX (2.6) [83], 3C9L (2.65) [83] | ||
| Point mutations | Agonist | 11-trans-retinal, Ga peptide | 2X72 (3.0) [122], 3PQR (2.85) [123], 3PXO (3.0) [123] | |
| 9-cis-retinal | 2PED (2.95) 3385 [85] | |||
| 2J4Y (3.4) 3 [83], 3C9M (3.4) [83] | ||||
| Rhodopsin (squid) | Inverse agonist | 11-cis-retinal | 2ZIY (3.7) [86] |